BioCentury | Aug 14, 2020
Finance

Aug. 13 Quick Takes: Qiagen shareholders opt for independence; plus IPO terms from Inhibrx, Harmony and more from Biohaven-Royalty, Scioto, Bodyport, immunoSCAPE

...led by Anzu Partners, with participation from University of Tokyo Edge Capital and Indonesian firm NPR...
BioCentury | Jul 18, 2019
Distillery Therapeutics

Small molecule NPR1 inhibitors for itch

...itch. The compound had plasma and CNS half-lives of 0.5 hours in healthy mice. TARGET/MARKER/PATHWAY: Natriuretic peptide receptor...
...Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, Md. email: mark.hoon@nih.gov Hongjiang Li NIH Natriuretic peptide receptor...
BioCentury | May 8, 2019
Company News

Why dwarfism start-up Therachon picked Pfizer takeout over IPO

...FGFR3 (CD333) - Fibroblast growth factor receptor 3; GLP-2 - Glucagon-like peptide-2; NPR2 (NPRB) - Natriuretic peptide receptor...
BioCentury | Mar 21, 2018
Company News

Weather delay for achondroplasia meeting

...CNP; NPPC) analog resistant to neutral endopeptidase (neprilysin; MME; NEP; CD10) digestion, which binds to natriuretic peptide receptor...
BioCentury | Apr 6, 2017
Targets & Mechanisms

Competing for growth

...CD333) - fibroblast growth factor receptor 3; MAPK (ERK) - MAP kinase; NPR2 (NPRB) - natriuretic peptide receptor...
...Fibroblast growth factor FGFR3 (CD333) - Fibroblast growth factor receptor 3 NPR2 (NPRB) - Natriuretic peptide receptor...
BioCentury | Dec 14, 2016
Clinical News

Vosoritide: Ph III started

...Co. Ltd. (Tokyo:4519), Tokyo, Japan Product: Vosoritide (BMN 111) (formerly BMN-111) Business: Musculoskeletal Molecular target: Natriuretic peptide receptor...
...over 1 year; proportionality and functionality Status: Phase III started Milestone: NA Julian Zhu BMN 111 Vosoritide BioMarin Pharmaceutical Inc. Natriuretic peptide receptor...
BioCentury | Apr 13, 2015
Clinical News

Cenderitide: Completed Phase II enrollment

...Natriuretic peptide receptor A (NPR1) (NPRA); Natriuretic peptide receptor B (NPR2) (NPRB) Description: Selective natriuretic peptide receptor A (NPR1; NPRA) and natriuretic peptide receptor...
BioCentury | Mar 9, 2015
Clinical News

Cenderitide: Phase II started

...Business: Cardiovascular Molecular target: Natriuretic peptide receptor A (NPR1) (NPRA) ; Natriuretic peptide receptor B (NPR2) (NPRB) Description: Selective natriuretic peptide receptor...
...A (NPR1) (NPRA) ; Natriuretic peptide receptor B (NPR2) (NPRB) Description: Selective natriuretic peptide receptor A (NPR1; NPRA) and natriuretic peptide receptor...
BioCentury | Nov 24, 2014
Company News

Medtronic, Capricor Therapeutics deal

...awards or settlements received by Capricor from enforcement of the patents. Cenderitide is a selective natriuretic peptide receptor...
BioCentury | Jul 15, 2013
Company News

Capricor, Nile Therapeutics deal

...stem cells (CDCs). Nile's cenderitide , a selective natriuretic peptide receptor A ( NPR1 ; NPR1) and natriuretic peptide receptor...
Items per page:
1 - 10 of 62